ASSOTIATION OF THE GENETIC POLYMORPHISM E670G OF THE PCSK-9 AND THE SEVERITY OF THE CAROTID ATHEROSCLEROSIS IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA IN UZBEK POPULATION
Objective: to study the severity of carotid artery atherosclerosis in patients with heterozygous familial hypercholesterolemia in the Uzbek population, depending on the level of PCSK-9 and the genetic polymorphism E670G of the PCSK-9 gene.Material and methods. The study included 57 patients with chr...
Main Authors: | R. B. Alieva, S. U. Hoshimov, Sh. S. Ahmedova, F. M. Bekmetova, A. B. Shek, R. D. Kurbanov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
InterMedservice
2019-09-01
|
Series: | Евразийский Кардиологический Журнал |
Subjects: | |
Online Access: | https://www.heartj.asia/jour/article/view/335 |
Similar Items
-
E670G PCSK9 polymorphism in HeFH & CAD with diabetes: is the bridge to personalized therapy within reach?
by: Rano Alieva, et al.
Published: (2023-11-01) -
Real‐World Effectiveness of PCSK9 Inhibitors in Reducing LDL‐C in Patients With Familial Hypercholesterolemia in Italy: A Retrospective Cohort Study Based on the AIFA Monitoring Registries
by: Marcello Arca, et al.
Published: (2023-11-01) -
Optimized Treatment of Refractory Hypercholesterolemia in Patients With Atherosclerotic Cardiovascular Disease or Heterozygous Familial Hypercholesterolemia With Alirocumab (OPTIMIZE)
by: Isabella Sudano, et al.
Published: (2022-07-01) -
PCSK9 Gene E670G Polymorphism and Coronary Artery Disease: An Updated Meta-Analysis of 5,484 Subjects
by: Yan-yan Li, et al.
Published: (2020-11-01) -
Long-term cancer risk in heterozygous familial hypercholesterolemia relatives: a 25-year cohort study
by: Kasper Aalbæk Kjærgaard, et al.
Published: (2022-07-01)